These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 23971898

  • 1. Novel diagnostic and prognostic biomarkers in biliary tract cancer.
    Skipworth JR, Timms JF, Pereira SP.
    Expert Opin Med Diagn; 2013 Sep; 7(5):487-99. PubMed ID: 23971898
    [Abstract] [Full Text] [Related]

  • 2. Mac-2-binding protein is a diagnostic marker for biliary tract carcinoma.
    Koopmann J, Thuluvath PJ, Zahurak ML, Kristiansen TZ, Pandey A, Schulick R, Argani P, Hidalgo M, Iacobelli S, Goggins M, Maitra A.
    Cancer; 2004 Oct 01; 101(7):1609-15. PubMed ID: 15378479
    [Abstract] [Full Text] [Related]

  • 3. Gallbladder bile tumor marker quantification for detection of pancreato-biliary malignancies.
    Brockmann J, Emparan C, Hernandez CA, Sulkowski U, Dietl KH, Menzel J, Wolters H, Glodny B, Senninger N.
    Anticancer Res; 2000 Oct 01; 20(6D):4941-7. PubMed ID: 11326643
    [Abstract] [Full Text] [Related]

  • 4. Circulating MicroRNAs as Biomarkers in Biliary Tract Cancers.
    Letelier P, Riquelme I, Hernández AH, Guzmán N, Farías JG, Roa JC.
    Int J Mol Sci; 2016 May 23; 17(5):. PubMed ID: 27223281
    [Abstract] [Full Text] [Related]

  • 5. Human bile as a rich source of biomarkers for hepatopancreatobiliary cancers.
    Gowda GA.
    Biomark Med; 2010 Apr 23; 4(2):299-314. PubMed ID: 20406071
    [Abstract] [Full Text] [Related]

  • 6. [Surgical treatment of cancer of the biliary tract and gall bladder].
    Nakayama T, Shimada S, Kinoshita H, Kosuga K.
    Gan To Kagaku Ryoho; 1991 Jul 23; 18(8):1264-8. PubMed ID: 2069396
    [Abstract] [Full Text] [Related]

  • 7. [The incidence, clinical and biologic diagnosis, and prognosis of cancer of the exocrine pancreas and biliary tract].
    Gainant A, Cubertafond P.
    Rev Prat; 1989 Oct 01; 39(22):1933-7. PubMed ID: 2814274
    [Abstract] [Full Text] [Related]

  • 8. The efficacy of biliary and serum macrophage inhibitory cytokine-1 for diagnosing biliary tract cancer.
    Sugimoto M, Takagi T, Konno N, Suzuki R, Asama H, Watanabe K, Nakamura J, Waragai Y, Kikuchi H, Takasumi M, Sato Y, Hikichi T, Ohira H.
    Sci Rep; 2017 Aug 23; 7(1):9198. PubMed ID: 28835660
    [Abstract] [Full Text] [Related]

  • 9. Biomarkers in bladder cancer.
    Proctor I, Stoeber K, Williams GH.
    Histopathology; 2010 Jul 23; 57(1):1-13. PubMed ID: 20579130
    [Abstract] [Full Text] [Related]

  • 10. Usefulness of bile cytology in the diagnostic management of patients with biliary tract obstruction.
    Cobb CJ, Floyd WN.
    Acta Cytol; 1985 Jul 23; 29(2):93-100. PubMed ID: 2984868
    [Abstract] [Full Text] [Related]

  • 11. Comprehensive review of the diagnosis and treatment of biliary tract cancer 2012. Part I: diagnosis-clinical staging and pathology.
    Marsh Rde W, Alonzo M, Bajaj S, Baker M, Elton E, Farrell TA, Gore RM, Hall C, Nowak J, Roy H, Shaikh A, Talamonti MS.
    J Surg Oncol; 2012 Sep 01; 106(3):332-8. PubMed ID: 22488652
    [Abstract] [Full Text] [Related]

  • 12. Amplification and overexpression of c-erbB-2, epidermal growth factor receptor, and c-met in biliary tract cancers.
    Nakazawa K, Dobashi Y, Suzuki S, Fujii H, Takeda Y, Ooi A.
    J Pathol; 2005 Jul 01; 206(3):356-65. PubMed ID: 15892172
    [Abstract] [Full Text] [Related]

  • 13. [Tumor markers for pancreatic and biliary tract cancer].
    Takezako Y, Okusaka T, Ueno H, Ikeda M, Morizane C, Najima M.
    Gan To Kagaku Ryoho; 2004 Sep 01; 31(9):1443-6. PubMed ID: 15446574
    [Abstract] [Full Text] [Related]

  • 14. Biomarkers vs conventional histological analysis to detect lymph node micrometastases in bladder cancer: a real improvement?
    Gazquez C, Ribal MJ, Marín-Aguilera M, Kayed H, Fernández PL, Mengual L, Alcaraz A.
    BJU Int; 2012 Nov 01; 110(9):1310-6. PubMed ID: 22416928
    [Abstract] [Full Text] [Related]

  • 15. Advances in biomarkers of biliary tract cancers.
    Hu J, Yin B.
    Biomed Pharmacother; 2016 Jul 01; 81():128-135. PubMed ID: 27261586
    [Abstract] [Full Text] [Related]

  • 16. [Tumor markers in the diagnosis of tumors of the liver and biliary tract].
    Marecek Z.
    Vnitr Lek; 1997 Mar 01; 43(3):167-70. PubMed ID: 9221578
    [Abstract] [Full Text] [Related]

  • 17. [Pancreatic and biliary tract cancers].
    Sawada T, Yamada N, Hirakawa K.
    Gan To Kagaku Ryoho; 2001 Jun 01; 28(6):865-71. PubMed ID: 11432359
    [Abstract] [Full Text] [Related]

  • 18. Expression and clinical significance of cell cycle regulatory proteins in gallbladder and extrahepatic bile duct cancer.
    Kim WB, Han HJ, Lee HJ, Park SS, Song TJ, Kim HK, Suh SO, Kim YC, Choi SY.
    Ann Surg Oncol; 2009 Jan 01; 16(1):23-34. PubMed ID: 18979138
    [Abstract] [Full Text] [Related]

  • 19. Deregulated MicroRNAs in Biliary Tract Cancer: Functional Targets and Potential Biomarkers.
    Mayr C, Beyreis M, Wagner A, Pichler M, Neureiter D, Kiesslich T.
    Biomed Res Int; 2016 Jan 01; 2016():4805270. PubMed ID: 27957497
    [Abstract] [Full Text] [Related]

  • 20. Diagnosis of biliary strictures in conjunction with endoscopic retrograde cholangiopancreaticography, with special reference to patients with primary sclerosing cholangitis.
    Lindberg B, Arnelo U, Bergquist A, Thörne A, Hjerpe A, Granqvist S, Hansson LO, Tribukait B, Persson B, Broomé U.
    Endoscopy; 2002 Nov 01; 34(11):909-16. PubMed ID: 12430077
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.